MET and thyroid gland papillary carcinoma: Since the MET promoter is a 697 bp 5′-untranslated region that contains a typical CpG island spanning, with a frequency of CpGs 10 times greater than in the total gene (Accession no. Z26936), in the present study, we have explored the possibility that an altered methylation status of the MET promoter is involved in the abnormal expression of Met protein in papillary carcinoma.